Modasa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 28.27%
(FY 2023)
- Profit 219.37%
(FY 2023)
- Ebitda 1419.38%
(FY 2023)
- Net Worth 47.86%
(FY 2023)
- Total Assets 137.22%
(FY 2023)
About Modasa Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rambhai Patel and Mehul Patel serve as directors at the Company.
- CIN/LLPIN
U51397GJ2011PTC065202
- Company No.
065202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Sabarkantha, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Modasa Pharmaceuticals Private Limited offer?
Modasa Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Antiallergic API, Nervous System and Antipsychotic API, Antipyretic and Analgesic API, Brain & Nervous System Drugs, Antimigraine Drug, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Modasa Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Patel  | Director | 09-Aug-2017 | Current |
| Rambhai Patel | Director | 29-Apr-2011 | Current |
Financial Performance of Modasa Pharmaceuticals.
Modasa Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.27% increase. The company also saw a substantial improvement in profitability, with a 219.37% increase in profit. The company's net worth Soared by an impressive increase of 47.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Modasa Pharmaceuticals?
Unlock access to Modasa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Modasa Pharmaceuticals?
Unlock and access historical data on people associated with Modasa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Modasa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Modasa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
